Arteriosclerosis, Vol 10, 1010-1019, Copyright © 1990 by American Heart Association

ARTICLES

Dysregulation of lipid metabolism in Tangier monocyte-derived macrophages

G Schmitz, H Fischer, M Beuck, KP Hoecker and H Robenek
Institut fur Klinische Chemie und Laboratoriumsmedizin, Westfalische Wilhelms-Universitat, Munster, FRG.

The cellular defect in Tangier mononuclear phagocytes (MNP) was shown to be associated with significant abnormalities in cellular phospholipid, triglyceride, and cholesteryl ester metabolism by using various radiolabeled precursors (32Pi, 3H-serine, 3H-choline, 14C- acetate, and 14C-oleic acid). Tangier MNP expressed increased rates of synthesis for phospholipids (twofold), triglycerides (fivefold), and cholesteryl esters (threefold) as compared to normal MNP when incubated in McCoy's medium containing 0.2% human serum albumin. The turnover rate of cellular phospholipids was also enhanced, while the turnover rates for triglycerides and cholesteryl esters were normal, thus leading to the accumulation of a larger pool of labeled triglycerides and cholesteryl esters in Tangier MNP. The individual phospholipid classes, phosphatidylcholine, sphingomyelin, phosphatidylethanolamine, and phosphatidylserine were similarly affected. Cholesterol loading led to approximately 30% down-regulation of phospholipid synthesis in normal cells, but Tangier MNP showed a smaller response. When nonloaded normal MNP were exposed to high density lipoprotein3 (HDL3), they diminished cellular cholesterol esterification mediated by acyl- CoA:cholesterol acyltransferase (ACAT); in Tangier MNP, ACAT activity increased in the presence of HDL3. When cholesterol-loaded normal and Tangier MNP were treated with HDL3, an up-regulation of phospholipid synthesis was observed in both cell types, but Tangier MNP showed a smaller response. We conclude that the defect in Tangier disease, which we recently described as a "disorder of intracellular traffic" (Schmitz et al. Proc Natl Acad Sci USA 1985;82:6305-6309), is associated with a dysregulation of cellular lipid metabolism, leading to an overproduction of triglycerides and esterified cholesterol and to enhanced synthesis and catabolism of phospholipids.

This article has been cited by other articles:

				G Kolovou, D Daskalova, K Anagnostopoulou, I Hoursalas, V Voudris, D P Mikhailidis, and D V Cokkinos Postprandial hypertriglyceridaemia in patients with Tangier disease J. Clin. Pathol., December 1, 2003; 56(12): 937 - 941. [Abstract] [Full Text] [PDF]

				M. E. Brousseau, E. J. Schaefer, J. Dupuis, B. Eustace, P. Van Eerdewegh, A. L. Goldkamp, L. M. Thurston, M. G. FitzGerald, D. Yasek-McKenna, G. O'Neill, et al. Novel mutations in the gene encoding ATP-binding cassette 1 in four Tangier disease kindreds J. Lipid Res., March 1, 2000; 41(3): 433 - 441. [Abstract] [Full Text]

				B. WEITKAMP, P. CULLEN, G. PLENZ, H. ROBENEK, and J. RAUTERBERG Human macrophages synthesize type VIII collagen in vitro and in the atherosclerotic plaque FASEB J, August 1, 1999; 13(11): 1445 - 1457. [Abstract] [Full Text]

				G. Plenz, S. Reichenberg, C. Koenig, J. Rauterberg, M. C. Deng, H. A. Baba, and H. Robenek Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Modulates the Expression of Type VIII Collagen mRNA in Vascular Smooth Muscle Cells and Both Are Codistributed During Atherogenesis Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1658 - 1668. [Abstract] [Full Text] [PDF]

				W. Drobnik, G. Liebisch, C. Biederer, B. Trumbach, G. Rogler, P. Muller, and G. Schmitz Growth and Cell Cycle Abnormalities of Fibroblasts From Tangier Disease Patients Arterioscler. Thromb. Vasc. Biol., January 1, 1999; 19(1): 28 - 38. [Abstract] [Full Text] [PDF]

				A. Cignarella, B. Brennhausen, A. von Eckardstein, G. Assmann, and P. Cullen Differential Effects of Lovastatin on the Trafficking of Endogenous and Lipoprotein-Derived Cholesterol in Human Monocyte–Derived Macrophages Arterioscler. Thromb. Vasc. Biol., August 1, 1998; 18(8): 1322 - 1329. [Abstract] [Full Text] [PDF]

				A.T. Remaley, U.K. Schumacher, J.A. Stonik, B.D. Farsi, H. Nazih, and H.B. Brewer Decreased Reverse Cholesterol Transport from Tangier Disease Fibroblasts : Acceptor Specificity and Effect of Brefeldin on Lipid Efflux Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1813 - 1821. [Abstract] [Full Text]

				S. Mohr, P. Cullen, R. Schmidt, A. Cignarella, and G. Assmann Avoidance of False Positives in PCR-Based mRNA Differential Display During Investigation of Nonstandardized Tissues or Cells Clin. Chem., January 1, 1997; 43(1): 182 - 184. [Full Text]

				Y. Huang, A. von Eckardstein, S. Wu, C. Langer, and G. Assmann Generation of Pre-ß1-HDL and Conversion Into {alpha}-HDL : Evidence for Disturbed HDL Conversion in Tangier Disease Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1746 - 1754. [Abstract] [Full Text]

				W. Drobnik, C. Mollers, T. Resink, and G. Schmitz Activation of Phosphatidylinositol-Specific Phospholipase C in Response to HDL3 and LDL Is Markedly Reduced in Cultured Fibroblasts From Tangier Patients Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1369 - 1377. [Abstract] [Full Text]

				G. Rogler, B. Trumbach, B. Klima, K. J. Lackner, and G. Schmitz HDL-Mediated Efflux of Intracellular Cholesterol Is Impaired in Fibroblasts From Tangier Disease Patients Arterioscler. Thromb. Vasc. Biol., May 1, 1995; 15(5): 683 - 690. [Abstract] [Full Text]